1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Rituximab may Help Treat Chronic Fatigue Syndrome – MedIndia

October 21, 2011Monoclonal Anti-CD20 Antibodiesadmin

MedIndia

Rituximab may Help Treat Chronic Fatigue Syndrome
MedIndia
The anti-cancer drug Rituximab may help alleviate symptoms of chronic fatigue syndrome (CFS), suggesting that the source of the disease could lie in the immune system. ...
Rituximab trial remissions suggest CFS is an autoimmune illness - for subset ...ProHealth
Rituximab proven to treat ME/CFSPharmaceutical Business Review
Cancer Drug May Also Treat Chronic Fatigue SyndromeWebMD
News 10NBC
all 5 news articles »

Post navigation

← National self-sufficiency in organ donation is essential, say experts – BioEdge European Medicines Agency Agrees to Precautionary Recall of Advagraf 0.5 Mg … – PharmaLive.com (press release) →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos